Lotte Corp postpones bond issuance The company makes the decision after being picked as preferred bidder for Ministop Korea
Translated by Kim So-in 공개 2022-01-25 08:14:57
이 기사는 2022년 01월 25일 08시11분 thebell에 표출된 기사입니다
Lotte Corp, the holding company of South Korean retail giant Lotte Group, has postponed its plan to issue a bond after being named as a preferred bidder for Ministop Korea.Lotte Corp has cancelled its plan to launch a bookbuilding process initially scheduled for January 21, according to industry sources. The company has made the decision to notify potential investors about the fact that it has been selected as the preferred bidder to acquire Ministop Korea.
The registration statement that Lotte Corp issued on January 18 didn’t include information on its possible acquisition of Ministop Korea. The race for the convenience store chain included Lotte Corp, which participated in the final round of bidding in December 2021, Shinsegae’s convenience store chain Emart24, and a consortium consisting of Nepstone Holdings.
Lotte Corp offered 300 billion won for Ministop Korea, outbidding the two rivals which offered some 200 billion won.
“We have decided to postpone the bond offering to a later date in consideration of various circumstances such as investor protection,” said the company. “We will cancel the remaining schedule with the consent of the lead bookrunner.”
Lotte Corp planned to raise up to 500 billion won in its bond issuance. With the cancellation, the company will have to come up with a new timeline for its bond issuance and resubmit its registration statement.
The company is expected to resume the process before its debt reaches maturity in April, depending on response from investors. (Reporting by Chan-mi Oh)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [thebell interview]"젠시, AI가 상품 소개 작성…로봇 촬영까지"
- LG이노텍·LG디스플레이, 유리기판 사업화 시동
- [Company Watch]시노펙스, 반도체 필터 성장에 혈액투석 신사업까지 '본궤도'
- [i-point]제이엘케이, 'JLK-LVO' 혁신의료기기 통과
- [i-point]포커스에이아이, 차세대 나라장터 구축유공 표창장 수상
- [thebell interview]"매출 1000억 이어 신사업 두 마리 토끼 잡을 것"
- [Red & Blue]테마 바람 탄 아이스크림에듀, 사업 경쟁력 '재조명'
- 제노스코 '상장 불발' 이후, 오스코텍·메리츠 복잡한 셈법
- [클리니컬 리포트]동아ST의 메타비아, 위고비 빈틈 겨냥 '비만약' 내약성 입증
- 유유제약, 수익성 개선에 쌓이는 현금 '차입 축소' 행보